Barclays’s Corteva CTVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-8,000
Closed -$536K 5117
2025
Q4
$536K Buy
8,000
+4,000
+100% +$259K ﹤0.01% 3805
2025
Q3
$271K Sell
4,000
-166,200
-98% -$12M ﹤0.01% 4160
2025
Q2
$12.7M Buy
+170,200
New +$11.3M ﹤0.01% 1402
2023
Q4
Sell
-154,800
Closed -$7.92M 5241
2023
Q3
$7.92M Buy
+154,800
New +$8.2M ﹤0.01% 1098
2021
Q4
Sell
-170,000
Closed -$7.15M 4202
2021
Q3
$7.15M Buy
+170,000
New +$7.35M ﹤0.01% 1386
2021
Q1
Sell
-1,122
Closed -$43K 4775
2020
Q4
$43K Hold
1,122
﹤0.01% 4472
2020
Q3
$32K Hold
1,122
﹤0.01% 4778
2020
Q2
$30K Sell
1,122
-1,584
-59% -$41.2K ﹤0.01% 5106
2020
Q1
$64K Sell
2,706
-11,451
-81% -$315K ﹤0.01% 5070
2019
Q4
$418K Sell
14,157
-25,938
-65% -$687K ﹤0.01% 4449
2019
Q3
$1.12M Sell
40,095
-228,921
-85% -$6.62M ﹤0.01% 3554
2019
Q2
$7.96M Buy
+269,016
New +$7.24M ﹤0.01% 1506

Other funds holding CTVA

Barclays's CTVA Position: Q2 2026 in Review

Barclays reduced its Corteva (CTVA) stake by 29% in Q2 2026, selling an estimated $31.6M and leaving 959,969 shares worth $81.3M. The position accounts for 0.02% of the portfolio, ranked #567.

Barclays first reported a position in CTVA in Q2 2019 and has held it in 29 quarters since. The position peaked at $187M in Q4 2025. 1,494 funds tracked by Wall St. Rank hold CTVA as of Q2 2026.

  • Barclays held 959,969 shares of Corteva worth $81.3M as of Q2 2026.
  • Barclays sold 393,218 Corteva shares in Q2 2026, an estimated $31.6M.
  • Corteva made up 0.02% of Barclays's portfolio in Q2 2026, its #567 holding.
  • Barclays first reported a position in Corteva in Q2 2019 and has held it in 29 quarters since.
  • Barclays's Corteva position peaked at $187M in Q4 2025.
  • 1,494 funds tracked by Wall St. Rank held Corteva as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.